Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
EyePoint Pharmaceuticals is a US-based biopharmaceutical company specializing in innovative therapies for eye diseases. The company focuses on the development and commercialization of advanced drug delivery technologies designed to treat chronic retinal conditions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
EyePoint Pharmaceuticals is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
EyePoint Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -1.09 USD.
EyePoint Pharmaceuticals has beaten analyst EPS estimates in 0 of its last 5 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.